These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32511539)

  • 21. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
    Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN
    Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis and clinical assessment: an updated meta-analysis of randomized trials.
    Han X; Shi W; Yang Y
    J Thorac Dis; 2024 May; 16(5):2983-2993. PubMed ID: 38883686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review.
    Garcia MC; Tsang K; Lohit S; Deng J; Schneider T; Matos Silva J; Mbuagbaw L; Holbrook A
    Ann Pharmacother; 2024 Jul; 58(7):742-755. PubMed ID: 37881891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
    Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
    Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
    Di Stefano L; Ogburn EL; Ram M; Scharfstein DO; Li T; Khanal P; Baksh SN; McBee N; Gruber J; Gildea MR; Clark MR; Goldenberg NA; Bennani Y; Brown SM; Buckel WR; Clement ME; Mulligan MJ; O'Halloran JA; Rauseo AM; Self WH; Semler MW; Seto T; Stout JE; Ulrich RJ; Victory J; Bierer BE; Hanley DF; Freilich D;
    PLoS One; 2022; 17(9):e0273526. PubMed ID: 36173983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
    Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM
    J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review and Meta-Analysis of the Safety of Hydroxychloroquine in a Randomized Controlled Trial and Observational Studies.
    Konwar M; Maurya M; Thatte UM; Gogtay NJ; Bose D
    Curr Rev Clin Exp Pharmacol; 2022; 17(3):216-235. PubMed ID: 34455948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
    Agstam S; Yadav A; Kumar-M P; Gupta A
    Indian Pacing Electrophysiol J; 2021; 21(1):36-43. PubMed ID: 33075484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis.
    Landsteiner de Sampaio Amêndola I; Aires Pinheiro J; Póvoa P; Cés de Souza Dantas V; Serafim RB
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
    Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
    Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
    Nikolic RPA; Virk MK; Buhler KA; Costenbader KH; Choi MY; Weber BN
    J Cardiovasc Pharmacol; 2024 Aug; 84(2):158-169. PubMed ID: 38922589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine.
    Ngai J; Kalter M; Byrd JB; Racz R; He Y
    Front Pharmacol; 2022; 13():812338. PubMed ID: 35401219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
    De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
    Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
    Liu Y; Fu X; Xie C
    Medicine (Baltimore); 2020 Sep; 99(37):e22031. PubMed ID: 32925737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
    Das RR; Behera B; Mishra B; Naik SS
    Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
    Di Stefano L; Ogburn EL; Ram M; Scharfstein DO; Li T; Khanal P; Baksh SN; McBee N; Gruber J; Gildea MR; Clark MR; Goldenberg NA; Bennani Y; Brown SM; Buckel WR; Clement ME; Mulligan MJ; O'Halloran JA; Rauseo AM; Self WH; Semler MW; Seto T; Stout JE; Ulrich RJ; Victory J; Bierer BE; Hanley DF; Freilich D
    medRxiv; 2022 Aug; ():. PubMed ID: 35043124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.